期刊
AAPS JOURNAL
卷 19, 期 5, 页码 1276-1283出版社
SPRINGER
DOI: 10.1208/s12248-017-0097-1
关键词
cardiovascular disease; diabetes; GPCRs; G proteins; prostaglandins; type 2 diabetes
Cardiovascular disease is a common co-morbidity found with obesity-linked type 2 diabetes. Current pharmaceuticals for these two diseases treat each of them separately. Yet, diabetes and cardiovascular disease share molecular signaling pathways that are increasingly being understood to contribute to disease pathophysiology, particularly in pre-clinical models. This review will focus on one such signaling pathway: that mediated by the G protein-coupled receptor, Prostaglandin E-2 Receptor 3 (EP3), and its associated G protein in the insulin-secreting beta-cell and potentially the platelet, G(z). The EP3/G(z) signaling axis may hold promise as a dual target for type 2 diabetes and cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据